The potential to prevent the additional metabolic complications induced by GCs therapy, including -cell dysfunction, insulin resistance, and weight gain is especially important
Phytotherapy Research, 33 (12), 30903111
Other GLP-1 receptor agonists registered with Australias Therapeutic Goods Administration (TGA) include sulaglutide (sold as Trulicity), liraglutide (sold as Saxenda) and Tiezepatide (sold as Mounjaro), but only Ozempic is subsidised on the Pharmaceutical Benefits Scheme (PBS)
But its real and its called glutathione
doi: 10.1016/S1665-2681(19)31926-X 93
If you are concerned about how stopping GLP-1 medication might affect your eating, or if you have noticed that your relationship with food has become more difficult since starting these medications, we are here to help you find a way through that feels manageable and safe